Sign up to Seedtable
Get unlimited access to our database of 17,248 companies. Cancel anytime.
Full database access with no contact information. New companies added weekly.
- Access 17k companies (and growing) with unlimited exports
- Filter by geography, business model, industry, money raised and more
- Score to find fast-growing companies
- Likely to Outsource tag to understand if a company is looking for your services
- Verified email addresses so you can contact people directly
- Personalized 1:1 onboarding by a cold email expert
Full database access with verified contact info. New companies added weekly.
- Access 17k companies (and growing) with unlimited exports
- Filter by geography, business model, industry, money raised and more
- Score to find fast-growing companies
- Likely to Outsource tag to understand if a company is looking for your services
- Verified email addresses so you can contact people directly
- Personalized 1:1 onboarding by a cold email expert
All of Pro, plus we'll exclude your top three competitors as new Intel customers.
- Access 17k companies (and growing) with unlimited exports
- Filter by geography, business model, industry, money raised and more
- Score to find fast-growing companies
- Likely to Outsource tag to understand if a company is looking for your services
- Verified email addresses so you can contact people directly
- Personalized 1:1 onboarding by a cold email expert
Free plan includes the ability to browse the database and a list of the top 10 companies of the week, every Tuesday in your email. You need to upgrade if you want to see more than 10 companies, sort, filter or export data.
world-class organizations
69 Health Tech Startups in UK to Watch in 2024
How do we build this list?
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Skin care telehealth platform. |
$52M · Series B | Village Global, Index Ventures, Headline | 101 to 250 | Health Tech | B2C | London, UK | •••••••••••@getharley.com | |
Workflow automation platform for the life sciences industry. |
$40M · Series B | Dimension, Local Globe, Hummingbird Ventures | 51 to 100 | Health Tech, Machine Learning | B2B | London, UK | •••••••••••@automata.tech | |
Oophthalmic gene therapy company to treat blinding retinal illnesses. |
$120M · Series A | Syncona Partners LLP | 1 to 10 | Health Tech, Biotech | London, UK | •••••••••••@beacontx.com | ||
Biomedical research discovery tool. |
$60M · Series B | Index Ventures, ICONIQ Growth, Pentech Ventures | 51 to 100 | Health Tech, AI, Biotech, Pharma | B2B, SaaS | London, UK | •••••••••••@causaly.com | |
Developer of non-biological affinity reagents to accelerate the production of cell and gene therapies. |
$8M · Series A | Mercia Asset Management | 11 to 50 | Health Tech, Biotech | London, UK | •••••••••••@mipdiscovery.com | ||
Cera Care is a London-based technology-enabled home care company. |
$64M | Oltre Venture | 5001 to 10000 | Health Tech, Mobile, Service Industry, ElderTech | B2B, B2C | London, UK | •••••••••••@ceracare.co.uk | |
Intracellular screening platform. |
$51M · Series A | Columbus Venture Partners, British Patient Capital, Pfizer Venture Investments | 11 to 50 | Health Tech | Southampton, UK | •••••••••••@curvetx.com | ||
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments. |
$30M · Series A | Kindred Capital, Octopus Ventures, Amadeus Capital | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@oribiotech.com | |
Virtual reality healthcare training platform. |
$12M · Series A | Frog Capital, ACF Investors, QVentures | 1 to 10 | Health Tech, Edtech | B2B, SaaS | London, UK | •••••••••••@oxfordmedicalsimulation.com | |
Huma provides a digital health platform used for predictive care and research. |
$25M · Series B | Unilever Ventures, Samsung NEXT | 101 to 250 | Health Tech, Data and Analytics, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@huma.com | |
AI platform to map the human immune system. |
$14M · Series A | Molten Ventures, Life Extension Ventures | 11 to 50 | Health Tech, Biotech | London, UK | •••••••••••@imubiosciences.com | ||
Oviva digitizes the treatment of type 2 diabetes and obesity through a unique behavior change platform. |
$21M · Series B | AlbionVC, Earlybird Venture Capital, Partech Ventures | 251 to 500 | Health Tech, Foodtech, CPG & Consumer Goods, Ecommerce | B2B | London, UK | •••••••••••@oviva.com | |
Quell Therapeutics is a cell therapy company |
$45M · Series A | AlbionVC, Point72 Ventures | 101 to 250 | Health Tech, Edtech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@quell-tx.com | |
LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine. |
$25M | Kindred Capital, Atomico | 51 to 100 | Health Tech, AI, Biotech, Deep Tech, Machine Learning, Robotics, Manufacturing | B2B | London, UK | •••••••••••@labgeni.us | |
CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins. |
$50M · Series A | Khosla Ventures, General Catalyst | 1 to 10 | Health Tech, AI, Biotech, Data and Analytics | B2B | London, UK | •••••••••••@charmtx.com | |
At-home blood testing platform for cancer patients. |
$17M · Series A | Business Growth Fund, Parkwalk Advisors | 11 to 50 | Health Tech | B2B | London, UK | •••••••••••@entia.co | |
Fresha provides an online platform for booking beauty and wellness appointments with local businesses. |
$20M · Series B | Partech Ventures, Target Global, FJ Labs | 251 to 500 | Health Tech, Fashion, Ecommerce | B2B, B2C, SaaS | London, UK | •••••••••••@fresha.com | |
Gene silencing platform for the creation of programmable, allogeneic cell therapies. |
$16M · Seed | Mercia Asset Management, Calculus Capital, UK Innovation & Science Seed Fund | 1 to 10 | Health Tech, Biotech | London, UK | •••••••••••@laverocktx.com | ||
ReViral is a biotechnology company that develops and offers antiviral therapies for patients. |
$44M · Series C | Novo A/S, Andera Partners | 11 to 50 | Health Tech, Biotech, Pharma | B2B | London, UK | •••••••••••@reviral.co.uk | |
Numan is a startup which aims to tackle your tackle problem erectile dysfunction. |
$12M · Series A | Anthemis, VNV Global | 11 to 50 | Health Tech, Edtech | B2C | London, UK | •••••••••••@numan.com | |
AI-Powered healthcare platform. |
$5M · Seed | Hoxton Ventures, eHealth Ventures, AlbaCore Capital | 1001 to 5000 | Health Tech, AI | B2B, B2C | London, UK | •••••••••••@babylonhealth.com | |
We’re going where no-one has ever gone before. -- We’re fighting cancer. -- Lives are at stake. |
$22M · Series A | Hoxton Ventures, Atomico, Connect Ventures | 11 to 50 | Health Tech, AI | B2B | London, UK | •••••••••••@kheironmed.com | |
Palta is a health and wellbeing technology company |
$14M · Series A | Target Global, VNV Global | 501 to 1000 | Health Tech, Mobile | B2B, B2C | London, UK | •••••••••••@palta.com | |
Immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer. |
$17M · Seed | AlbionVC, Boxer Capital, Syncona Partners LLP | 101 to 250 | Health Tech, Biotech | B2B | London, UK | •••••••••••@achillestx.com | |
Generative AI platform for doctors. |
$4M · Seed | Khosla Ventures, Entrepreneur First | 1 to 10 | Health Tech, AI | B2B, SaaS | London, UK | •••••••••••@tortus.ai | |
Flo is an AI-powered women’s health app that supports women at every stage of their reproductive cycle. |
$7M · Series A | Target Global, VNV Global | 251 to 500 | Health Tech, Mobile, Business Intelligence | B2C, Freemium | London, UK | •••••••••••@flo.health | |
Therapy and coaching platform. |
$20M · Series B | Omers Ventures, Octopus Ventures | 51 to 100 | Health Tech, Fitness | B2B, B2C, Marketplace | London, UK | •••••••••••@helloself.com | |
Clinical trials platform. |
$18M · Series A | Valar Ventures, Creandum, Seedcamp | 11 to 50 | Health Tech, Biotech | B2B, SaaS | London, UK | •••••••••••@lindushealth.com | |
Surgical robotic system for minimal access surgery. |
$164M · Series D | SoftBank Group, Tencent, ABB Technology Ventures | 501 to 1000 | Health Tech, Robotics | B2B | Cambridge, UK | •••••••••••@cmrsurgical.com | |
Clinical-stage research for alzheimer’s disease. |
$58M · Series A | EQT Partners, UCL Technology Fund, Brandon Capital | 1 to 10 | Health Tech, Biotech | Reading, UK | •••••••••••@astronautx.bio | ||
Disease prevention testing platform. |
$44M · Series B | F-Prime Capital, Lansdowne Partners, Foresite Capital | 51 to 100 | Health Tech | Oxford, UK | •••••••••••@genomicsplc.com | ||
Precision software for eye surgery. |
$8M · Seed | Redalpine | 1 to 10 | Health Tech, Biotech | London, UK | •••••••••••@hypervisionsurgical.com | ||
Glorify is a mobile app designed to create space and structure for Christians to connect with God on a daily basis. |
$4M · Seed | A16Z, SoftBank Group | 51 to 100 | Health Tech, Mobile, Consumer Social, Media and Entertainement, Religion | B2C, Freemium, SaaS | London, UK | •••••••••••@glorify-app.com | |
Smart technology manufacturer for women. |
$3M · Seed | Nucleus Adventure Capital, NJF Capital, Octopus Ventures | 251 to 500 | Health Tech, Manufacturing | B2B, B2C | London, UK | •••••••••••@elvie.com | |
Fertility treatment for employees. |
$6M · Seed | Notion Capital, Passion Capital, Tiny VC | 1 to 10 | Health Tech | B2B | London, UK | •••••••••••@fertifa.com | |
Manual provides diagnostic tools and testing to help patients make health-related decisions. |
$6M · Seed | Felix Capital, Cherry Ventures, FJ Labs | 11 to 50 | Health Tech, Fashion, Pharma, Mobile, Ecommerce | B2C | London, UK | •••••••••••@manual.co | |
Immuno-oncology company treats cancer with antibodies. |
$2M · Series A | AlbionVC, Epidarex Capital, Novartis Venture Fund | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Genetics | B2B | London, UK | •••••••••••@epsilogen.com | |
Platform to automate the clinical studies process. |
$12M · Series A | Playfair, AlbionVC, Delin Ventures | 11 to 50 | Health Tech, Biotech | B2B | London, UK | •••••••••••@umed.io | |
Cancer treatment predictor software. |
$14M · Series A | Hoxton Ventures, Octopus Ventures, Fly Ventures | 11 to 50 | Health Tech, Biotech, Pharma | B2B | London, UK | •••••••••••@pearbio.com | |
User-owned genomics database platform. |
$20M · Series A | GEM Digital | 1 to 10 | Health Tech, Biotech | B2C | London, UK | •••••••••••@genomes.io | |
Florence is an online marketplace that connects vacant care home shifts to local nurses and carers looking for extra work |
$6M · Series A | AXA Venture Partners | 51 to 100 | Health Tech, Hiring and Recruitement, ElderTech | B2B, B2C, Marketplace | London, UK | •••••••••••@florence.co.uk | |
Diagnostic imaging platform. |
$12M · Series A | Triple Point Ventures | 51 to 100 | Health Tech | London, UK | •••••••••••@scan.com | ||
Developer of drugs to treat respiratory diseases. |
$2M · Series A | Forbion Capital Partners, Epidarex Capital, Imperial Innovations | 11 to 50 | Health Tech, Biotech | London, UK | •••••••••••@enterprisetherapeutics.com | ||
UMotif is a scalable and engaging patient-centred data capture platform for modern research. |
$6M · Series A | AlbionVC | 51 to 100 | Health Tech, Data and Analytics, Creative Tools | B2B, SaaS | London, UK | •••••••••••@umotif.com | |
Developer of therapeutics for chronic autoimmune and inflammatory diseases. |
$38M · Series A | Sofinnova Partners, GSK, SV Health Investors | 11 to 50 | Health Tech, Biotech | Oxford, UK | •••••••••••@sitryx.com | ||
Review platform for healthcare. |
$10M · Series A | Beringea, Keen Venture Partners, Amadeus Capital | 51 to 100 | Health Tech, Identity Management | B2B, B2C, Marketplace | London, UK | •••••••••••@doctify.com | |
Myricx Pharma is a drug discovery company focused on developing small molecule inhibitors. |
$6M · Seed | Sofinnova Partners | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | London, UK | •••••••••••@myricxpharma.com | |
Digital hospital of the future, providing elective medical procedures with a fully-digitised, personal and patient-first experience. |
$7M · Series A | Talis Capital, Cavalry Ventures Management, Signals Venture Capital | 11 to 50 | Health Tech | B2C, Marketplace | London, UK | •••••••••••@medbelle.com | |
Fitness game developers. |
$9M · Series A | Khosla Ventures, Heartcore, Tencent | 11 to 50 | Health Tech, Gaming, Sportstech, Fitness, Manufacturing | B2C | London, UK | •••••••••••@playquell.com | |
AR therapy for Parkinson's disease. |
$2M · Seed | Kluz Ventures, SFC Capital, Midlands Engine Investment Fund | 11 to 50 | Health Tech, AR / VR | B2C | London, UK | •••••••••••@strolll.co | |
Doccla is the virtual ward company. We are the pioneers of tech-agnostic virtual wards. |
$3M · Seed | General Catalyst, Giant Ventures, Speedinvest | 1 to 10 | Health Tech, Hardware, Data and Analytics, Manufacturing | B2B, SaaS | London, UK | •••••••••••@doccla.com | |
Mental health platform for employees. |
$370k · Angel | Felix Capital, EQT Ventures, Pentland Ventures | 51 to 100 | Health Tech, Fitness, Hiring and Recruitement, Enterprise Software | B2B, SaaS | London, UK | •••••••••••@unmind.com | |
Digital mental health platform for employees. |
$2M · Series A | IW Capital | 51 to 100 | Health Tech | B2B, SaaS | London, UK | •••••••••••@plummhealth.com | |
Skin Analytics uses artificial intelligence to screen for melanoma skin cancer. |
$5M · Series A | Hoxton Ventures | 11 to 50 | Health Tech, AI, Data and Analytics, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@skin-analytics.com | |
Hertility Health is on a mission to revolutionise the world of reproductive health. |
$5M · Seed | Local Globe | 11 to 50 | Health Tech | B2B, B2C | London, UK | •••••••••••@hertilityhealth.com | |
Digital health platform for underserved areas people. |
$380k · Pre Seed | Felix Capital, Seedcamp, AlbionVC | 101 to 250 | Health Tech, Service Industry | B2B, SaaS | London, UK | •••••••••••@peppy.health | |
We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins. |
$2M | Bessemer Venture Partners, Hoxton Ventures | 11 to 50 | Health Tech, Biotech, Pharma, Manufacturing | B2B | London, UK | •••••••••••@peptone.io | |
Clear aligner orthodontics. |
$2M · Seed | Balderton Capital | 11 to 50 | Health Tech | B2C | London, UK | •••••••••••@32co.com | |
Caeli Nova provides a technology system intended for the medicine and aviation sectors. |
$8M · Series A | LG Capital | 11 to 50 | Health Tech, Space Tech, Mobility & Transportation, Manufacturing | B2B | London, UK | •••••••••••@caelinova.com | |
Perfect Ward is the health and quality inspection solution. |
$5M · Series A | octopus investments | 11 to 50 | Health Tech, Deep Tech, Robotics, Manufacturing | B2B, SaaS | London, UK | •••••••••••@perfectward.com | |
Biomedical CloudOS data platform. |
$120k · Seed | Eurazeo, Connect Ventures, Techstars | 51 to 100 | Health Tech, Biotech, Data and Analytics, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@lifebit.ai | |
Thriva offers a personalized at-home finger-prick blood test which enables individuals to easily track and improve health. |
$7M · Series A | Target Global, Pembroke VCT | 101 to 250 | Health Tech, Consumer Social, Media and Entertainement, Ecommerce | B2C | London, UK | •••••••••••@thriva.co | |
Jude is a healthcare company dedicated to breaking bladder taboos, promoting incontinence awareness. |
$4M · Seed | Eka Ventures, Samos Investments, Joyance Partners | 11 to 50 | Health Tech, Manufacturing, Ecommerce | B2C | London, UK | •••••••••••@wearejude.com | |
Pathfinder is developing a novel catheter based system that provides a better way for patients to receive haemodialysis for kidney failure. |
$11M · Series A | Business Growth Fund, Parkwalk Advisors, Deepbridge Capital | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@pathfindermed.com | |
Patient management platform. |
$12M · Series B | YFM Equity Partners | 11 to 50 | Health Tech | London, UK | •••••••••••@drdoctor.co.uk | ||
eConsult Health is the leading digital triage provider to the NHS. |
$9M · Series A | Calculus Capital, Gresham House Ventures | 101 to 250 | Health Tech, Edtech | B2B, Marketplace | London, UK | •••••••••••@econsult.net | |
FitXR is on a mission to create a movement for movement |
$7M | Hiro Capital | 51 to 100 | Health Tech, Gaming, AR / VR, Sportstech, Fitness | B2C, SaaS | London, UK | •••••••••••@fitxr.com | |
Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies. |
$10M | Y Combinator, Pi Campus | 11 to 50 | Health Tech, Biotech, Robotics, Manufacturing, Business Intelligence | B2B | London, UK | •••••••••••@sixfold.bio | |
Digital healthcare program for people with ADHD. |
$11M · Series A | Hoxton Ventures, Octopus Ventures, Y Combinator | 11 to 50 | Health Tech, Mobile | B2C | London, UK | •••••••••••@getinflow.io |
Sign up to access our full database
Enter your email and get access to 17,000+ technology companies you can partner with.